LifeMD, Inc. (LFMDP)

US — Healthcare Sector
Peers: CDZIP  STRRP  FATBP  HCDIP  FBIOP 

Automate Your Wheel Strategy on LFMDP

With Tiblio's Option Bot, you can configure your own wheel strategy including LFMDP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol LFMDP
  • Rev/Share 5.1208
  • Book/Share -0.0091
  • PB -223.7613
  • Debt/Equity -10.7779
  • CurrentRatio 0.8206
  • ROIC 0.004

 

  • MktCap 549007008.0
  • FreeCF/Share 0.0734
  • PFCF 173.4057
  • PE -45.2911
  • Debt/Assets 0.3409
  • DivYield 0
  • ROE 2.3313

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
LFMD, LFMDP
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral

Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter

Read More
image for news LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
LFMD, LFMDP
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral

LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Steve Dechert - KeyBanc Steven Valiquette - Mizuho Securities Yi Chen - H.C. Wainwright Anderson Schock - B.

Read More
image for news LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript

About LifeMD, Inc. (LFMDP)

  • IPO Date 2021-10-05
  • Website https://www.lifemd.com
  • Industry Medical - Pharmaceuticals
  • CEO Mr. Justin Schreiber
  • Employees 304

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.